Complete response of huge buccal malignant melanoma in an octogenarian patient to arterial chemotherapy

Head Neck. 2015 Oct;37(10):E134-8. doi: 10.1002/hed.23941. Epub 2015 Jun 22.

Abstract

Background: Primary oral mucosal melanoma is uncommon. However, it is an aggressive entity, and the absence of a standardized treatment protocol makes for an extremely poor prognosis.

Methods: We described the clinical course and treatment by arterial chemotherapy of an 87-year-old patient with nonresectable huge buccal malignant melanoma. Continuous intra-arterial infusion of fluorouracil (50 mg/24 hours) and 1 intermittent weekly 10-mg shot of cisplatin were given.

Results: The patient with oral melanoma presented with a roughly 6- × 4-cm exophytic mass that was noticed on the right buccal mucosa. The buccal tumor regressed dramatically until complete disappearance of the tumor mass was achieved at 2.5 months after intra-arterial chemotherapy was initiated. In total, 2880 mg of fluorouracil and 80 mg of cisplatin were administrated. The side effects of intra-arterial chemotherapy were mild and tolerable.

Conclusion: Our data demonstrate that intra-arterial chemotherapy could be an alternative treatment for nonresectable buccal malignant melanoma.

Keywords: buccal mucosa; complete response; intra-arterial infusion chemotherapy; malignant melanoma; oral cavity.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cisplatin / administration & dosage*
  • Fluorouracil / administration & dosage*
  • Humans
  • Infusions, Intra-Arterial
  • Male
  • Melanoma / drug therapy*
  • Mouth Mucosa / pathology
  • Mouth Neoplasms / drug therapy*
  • Mouth Neoplasms / pathology
  • Remission Induction

Substances

  • Cisplatin
  • Fluorouracil